Kuwait approves Sotrovimab treatment for COVID-19: State media

Kuwait has approved GSK and Vir Biotechnology’s Sotrovimab as a treatment for coronavirus, state news KUNA reported on Wednesday.

Read the latest updates in our dedicated coronavirus section.

Kuwait is the second country in the Middle East to approve the use of the antibody treatment for mild to moderate COVID-19 cases, after the United Arab Emirates.

Kuwait also announced on Wednesday a $40 million donation to COVAX, the international program designed to help supply developing countries with vaccines against the disease, KUNA said.

Read more:

UAE approves GSK’s Sotrovimab COVID-19 drug for emergency use

Egypt aims to vaccinate 40 pct of population by end-2021: PM

UAE vaccinates 81 pct of eligible population over 16, over 92 pct of elderly